Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.

about

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.

Item

http://www.wikidata.org/entity/Q49399828

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Independent prognostic impact ...... early breast cancer subtypes.

@en

Independent prognostic impact ...... early breast cancer subtypes.

@nl

type

Item

label

Independent prognostic impact ...... early breast cancer subtypes.

@en

Independent prognostic impact ...... early breast cancer subtypes.

@nl

prefLabel

Independent prognostic impact ...... early breast cancer subtypes.

@en

Independent prognostic impact ...... early breast cancer subtypes.

@nl

P1476

Independent prognostic impact ...... r early breast cancer subtypes

@en

P2093

Arisa Nishimukai

http://www.w3.org/2001/XMLSchema#string

Ayako Kira

http://www.w3.org/2001/XMLSchema#string

Keiko Murase

http://www.w3.org/2001/XMLSchema#string

Koshi Oh

http://www.w3.org/2001/XMLSchema#string

Kouhei Akazawa

http://www.w3.org/2001/XMLSchema#string

Michiko Imamura

http://www.w3.org/2001/XMLSchema#string

Shintaro Michishita

http://www.w3.org/2001/XMLSchema#string

Takashi Morimoto

http://www.w3.org/2001/XMLSchema#string

Takashi Nomura

http://www.w3.org/2001/XMLSchema#string

Tomoko Higuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Tumour marker measurements in the diagnosis and monitoring of breast cancer.

Postoperative follow-up of breast cancer patients: overview and progress in the use of tumor markers.

Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes.

Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.

P2888

s12957-018-1325-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-018-1325-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kazuhiro Araki

Yasuo Miyoshi

P577

2018-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100997420

http://www.w3.org/2001/XMLSchema#string

P698

29433529

http://www.w3.org/2001/XMLSchema#string

P932

5809836

http://www.w3.org/2001/XMLSchema#string